Laurie Snyder
Duke University · Duke University Medical Center: Transplantation
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Laurie Snyder as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:49 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03805178 · Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and DesensitizationDuke University · withdrawn · Lung Transplant Rejection, Antibody-mediated Rejection · principal investigator
- N/ANCT03300882 · PREDICT Cytomegalovirus (CMV)National Institute of Allergy and Infectious Diseases (NIAID) · completed · Lung Transplant · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical and Biological Factors Predicting Lung Transplant Textbook Outcomes (U01)U01HL163300 · NHLBI · DUKE UNIVERSITY · fiscal years 2022 to 2026 · $370,073 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:49 UTC. The ranking covers the 200 most relevant of 34 PubMed records, and a shared surname and initials can bring in a namesake. All 34 on PubMed
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.Nature · 2010755 citationsRCR 19.7
- 163 citationsRCR 6.6
- Coping with dementia: evaluation of four nonpharmacologic interventions.Int Psychogeriatr · 2000120 citationsRCR 4.4
- Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial.Ann Intern Med · 198796 citationsRCR 5.3
- Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis).Am J Hematol · 201580 citationsRCR 2.7
- Early-stage memory loss support groups: outcomes from a randomized controlled clinical trial.J Gerontol B Psychol Sci Soc Sci · 201077 citationsRCR 3.2
- 72 citationsRCR 4.3
- Oral trehalose supplementation improves resistance artery endothelial function in healthy middle-aged and older adults.Aging (Albany NY) · 201667 citationsRCR 2.3
- Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation.Am J Transplant · 200765 citationsRCR 2.0
- Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.Int Clin Psychopharmacol · 201163 citationsRCR 2.1